Using real-world cancer registration data to evaluate treatment rates for women with ovarian cancer in England - results from National ovarian cancer audit

被引：0
|
作者：
Zachou, Georgia [1 ,2 ]
Hutchings, Andrew [1 ,2 ]
Boudour, Joanne [1 ]
Gurol-Urganci, Ipek [1 ,2 ]
Van Der Meulen, Jan [1 ,2 ]
Michael, Agnieszka [3 ]
Sundar, Sudha [4 ,5 ]
机构：
[1] Royal Coll Surgeons England, Clin Effectiveness Unit, Natl Ovarian Canc Audit, London, England
[2] London Sch Hyg & Trop Med, London, England
[3] Univ Surrey, Surrey Clin Trials Unit, Guildford, England
[4] Univ Birmingham, Gynaecol Canc Surg & Clin Acad, Birmingham, England
[5] Sandwell & West Birmingham NHS Trust, City Hosp, Pan Birmingham Gynaecol, Birmingham, England
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.466
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV347/#115
引用
收藏
页码：A265 / A265
页数：1
相关论文
共 50 条
  • [31] Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data
    Hurry, Manjusha
    Hassan, Shazia
    Seung, Soo Jin
    Walton, Ryan N.
    Elnoursi, Ashlie
    Mcgee, Jacob D.
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2021, 8 (02): : 114 - 121
  • [32] REAL WORLD TREATMENT PATTERNS OF PATIENTS WITH OVARIAN CANCER: ANALYSIS OF TARGETED THERAPIES IN THE FRENCH NATIONAL CLAIMS DATA
    Wu, E.
    Ben-Hamadi, R.
    Jenkins, M.
    Duberga, J.
    Lopez, J.
    Viola, M.
    Zhou, J.
    VALUE IN HEALTH, 2021, 24 : S66 - S66
  • [33] Treatment strategies for recurrent ovarian cancer in older adult patients in Japan: a study based on real-world data
    Kato, Mayumi Kobayashi
    Yunokawa, Mayu
    Bun, Seiko
    Shimoi, Tatsunori
    Yonemori, Kan
    Miyasaka, Naoyuki
    Kato, Tomoyasu
    Tamura, Kenji
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (05) : 1335 - 1341
  • [34] Treatment strategies for recurrent ovarian cancer in older adult patients in Japan: a study based on real-world data
    Mayumi Kobayashi Kato
    Mayu Yunokawa
    Seiko Bun
    Tatsunori Shimoi
    Kan Yonemori
    Naoyuki Miyasaka
    Tomoyasu Kato
    Kenji Tamura
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 1335 - 1341
  • [35] Real world challenges and disparities in the systemic treatment of ovarian cancer
    Nogueira-Rodrigues, Angelica
    Giannecchini, Giovanna Vieira
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2024, 185 : 180 - 185
  • [36] Impact of HIPEC introduction in cytoreduction for ovarian cancer of ovarian origin: a real-world population study
    Mendez, Blanca Valenzuela
    Quenet, Francois
    Thezenas, Simon
    Carrere, Sebastien
    Maurregot, Anne
    Sgarbura, Olivia
    Colombo, Pierre-Emmanuel
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A423 - A424
  • [37] REAL-WORLD OVARIAN CANCER MORTALITY OUTCOMES IN A BRAZILIAN REFERENCE WOMEN HEALTHCARE PUBLIC HOSPITAL
    Mattar, A.
    Bernardino, G.
    Rodrigues, L.
    Alemar, M.
    Filho, R. C. S.
    Navarro, P.
    Arakelian, R.
    Piotto, G.
    de, Almeida M. S.
    Gebrim, L. H.
    Tanaka, S. Y.
    VALUE IN HEALTH, 2024, 27 (06) : S394 - S395
  • [38] Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States
    Monberg, Matthew J.
    Hall, Jennifer P.
    Moon, Rebecca
    Khela, Keerun
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (06) : 1252 - 1261
  • [39] Bevacizumab for Ovarian Cancer at High Risk of Progression: Reproducibility of Trial Results in 'Real-world' Patients
    Bertelli, Gianfilippo
    Drews, Florian
    Lutchman-Singh, Kerryn
    ANTICANCER RESEARCH, 2016, 36 (09) : 4947 - 4950
  • [40] How to start niraparib in real-world Asian ovarian cancer patients?
    Hong, Sook-Hee
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (02)
12345